Attorneys

Member

Kimberly Vines Ph.D.

Alexandria, VA

404-739-8815

Kimberly Vines is a patent attorney with expertise in prosecuting U.S., foreign, and international applications in the areas of polymer and materials science; pharmaceuticals and pharmaceutical formulation; agricultural chemicals and their formulations; organometallic compounds; and biotechnology. She practices all aspects of patent prosecution including non-infringement and invalidity opinions. Her doctoral thesis was directed to the design and synthesis of novel RXR-selective retinoids as breast cancer chemopreventive agents. Her post-doctoral research was directed to the synthesis of natural products such as Epothilone B and Pseudolaric Acid B as well as anti-malarial compounds.

Capabilities

Practice Areas

Biotechnology/Life Sciences

Chemistry & Materials

Health Care – Life Sciences Technology & Commercialization

Intellectual Property & Technology

Patent Prosecution & Protection

Recent News, Articles & Speaking Engagements

Arguing Unexpected Results Supported by a Rule 132 Declaration: A "Deep Dive" with Ex Parte Eidschun

AIPLA Chemical Practice Chronicles, Vol. 13, Issue 1, Spring 2025

Pre-AIA Patent Applications Filed Before but Published After the Priority Date of a Challenged Patent are “Printed Publications” for IPRs

with Samantha Page Ph.D.,

Stites & Harbison Client Alert, January 21, 2025

Southeast-based law firm poaches Cantor Colburn attorneys as part of CT, Northeast expansion

by Harriet Jones, Hartford Business Journal, October 14, 2024

with Grant M. Ehrlich Ph.D., Youngmin Lee Ph.D., Helena M. Lovick Ph.D., Samantha Page Ph.D. and Wanli Wu

Stites & Harbison Eyes Conn. Office With Patent Team Pickup

by Martin Bricketto, Law360, September 12, 2024

with Grant M. Ehrlich Ph.D., Youngmin Lee Ph.D., Helena M. Lovick Ph.D., Samantha Page Ph.D. and Wanli Wu

Talk of the Town: Stites & Harbison Expands Intellectual Property Practice With Addition of New Attorneys and Patent Agents

by Editor, Attorney At Law Magazine, September 11, 2024

with Grant M. Ehrlich Ph.D., Youngmin Lee Ph.D., Helena M. Lovick Ph.D., Samantha Page Ph.D. and Wanli Wu

The On-Sale Bar After High Court Helsinn Ruling

IP Law360, January 31, 2019

Federal Circuit Reduces Certainty - Multilayer Stretch Film Holdings, Inc. v. Berry Plastics Corp.

Chemical Practice Chronicles, pp. 16-21, Fall 2016

Further Erosion of Patent Protection for Diagnostics: The Federal Circuit Denies En Banc Rehearing in Ariosa Diagnostics, Inc. v. Sequenom, Inc.

co-author, AIPLA Quarterly Journal, Vol. 44, No. 3, pp. 437-458, Summer 2016

Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention

Bioorganic & Medicinal Chemistry, 22, 178-85 (2014)

Syntheses of Benzo(b)furna-6-carbonitrile and 6-cyanobenzo(b)furan-2-boronic acid pinacol ester

Synthetic Communications, 43(14), 1974-1979, 2013

Convenient one-pot synthesis of 4-subsituted-2,6-dihalopyridines: valuable building blocks for medicinally active heterocycles

Abstracts of Papers, 240th American Chemistry Society National Meeting, Boston, Mass. (2010)

Progress towards the total synthesis of Pseudolaric acid B: a novel antipneumocystic and antifungal natural product

Abstracts of Papers, 228th American Chemistry Society National Meeting, Philadelphia, Penn., 2004

Total syntheses of Epothilones B and D

Journal of Organic Chemistry, 69(26), 9269-84, 2004

Synthesis of 1-aryl-7-substituted phthalazines as parasite cysteine protease inhibitors

Abstracts of Papers, 225th American Chemistry Society National Meeting, New Orleans, La., 2003

Total synthese of Epothilones B and D amenable to large-scale preparation

Abstracts of Papers, 225th American Chemical Society National Meeting, New Orleans, La., 2003

9cUAB30, an RXR-specific retinoid, and/or Tamoxifen in the prevention of methylnitrosourea-induced mammary cancers

Cancer Letters, 201(1), 17-24, 2003

Conformationally defined retinoic acid analogues

5. Large-scale synthesis and mammary cancer chrmopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-Dihydro-1'(2'H)-napthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic Acid (9cUAB30), Journal of Medicinal Chemistry, 46 (17), 3766-69, 2003

Synthesis and breast cancer chemoprevention for UAB30 and analogs, receptor-selective retinoids

Book of Abstracts, 218th American Chemistry Society National Meeging, New Orleans, La., 1999

Bar Admissions

Alabama

United States Patent and Trademark Office

Memberships

Intellectual Property Owners Association (IPO)

,

Member; U.S. Patent Office Practice Committee, Member (2023)

American Intellectual Property Law Association (AIPLA)

,

Member

American Chemical Society

,

Member

Education

J.D.,

2014

University of Alabama School of Law

Org / Honor

Alabama Law Review, Junior Editor (2012-13); Senior Editor (2013-14)

Best Paper: Antitrust, May 2012

Best Paper: Criminal Law, December 2011

Best Paper: Legal Writing, December 2011

Ph.D., Organic Chemistry,

2001

University of Alabama

Org / Honor

Thesis: Design of conformationally defined retinoids: sythesis nuclear receptor binding, and transcriptional activity of derivatives of (9Z)-UAB30

Graduate Student of the Year (Chemistry Department), May 2000

B.S., Chemistry,

1993

University of Alabama

Org / Honor

Teaching Assistant, General Chemistry, Biochemisrty and Organic Chemistry (1995-2001)

More Than Stites & Harbison

Kimberly’s doctoral thesis was directed to the design and synthesis of novel RXR-selective retinoids as breast cancer chemopreventive agents. Her post-doctoral research was directed to the synthesis of natural products such as Epothilone B and Pseudolaric Acid B as well as anti-malarial compounds. Prior to practicing law, she worked as a chemist at several companies in the greater Boston area.

Accolades

Best Lawyers in America®, Ones To Watch, Intellectual Property Law and Patent Law (2025)

Contact Resources

Kimberly Vines Ph.D.'s PDF Kimberly Vines Ph.D.'s Contact VCF

See more related to Kimberly Vines

Client Alerts

Pre-AIA Patent Applications Filed Before but Published After the Priority Date of a Challenged Patent are “Printed Publications” for IPRs

On January 14, 2025, the Court of Appeals for the Federal Circuit (CAFC) issued a ruling in Lynk Labs, Inc. v. Samsung Electronics Co. Ltd., No. 23-2346, clarifying whether a patent application that is § 102(e)(1) prior art qualifies as a prior art printed publication in an IPR proceeding. The...
by Samantha Page Ph.D. and Kimberly Vines Ph.D.

January 21, 2025

Press Releases

Stites & Harbison Expands Intellectual Property Practice with Addition of New Attorneys and Patent Agents

ALEXANDRIA, Va.—Stites & Harbison, PLLC is pleased to announce the addition of three attorneys and three patent agents to the firm’s Intellectual Property & Technology Service Group. All of the individuals join from one of the nation’s largest full-service intellectual property law firms. With the additions, Stites & Harbison will...
by Stites & Harbison, PLLC

September 12, 2024

Press Releases

Stites & Harbison, PLLC Lawyers Named to 2025 Best Lawyers® Publications

Honorees Include 12 as “Lawyer of the Year,” 98 in Best Lawyers in America® and 31 in Best Lawyers: Ones to Watch® in America LOUISVILLE, Ky.—Stites & Harbison, PLLC is pleased to announce that 98 of its lawyers are included in the 2025 edition of The Best Lawyers in America®....
by Stites & Harbison, PLLC

August 16, 2024